Cleary Gottlieb Steen & Hamilton (Washington)

Matthew D. Slater

Cleary Gottlieb Steen & Hamilton (Washington)
Lawyer (Senior Counsel)

Matthew D. Slater’s practice focuses on international investment-treaty and commercial arbitration and litigation involving the highest stakes and cutting-edge issues. In his international arbitration and litigation practice, Matt often represents foreign sovereign governments and government agencies and instrumentalities. He also regularly represents clients in international litigation in a diverse range of matters in U.S. courts often involving cross-border coordination with courts around the world. Matt is also active in the firm’s pro bono practice. Matt joined the firm in 1985 and became a partner in 1992. In 1995, he was appointed principal deputy general counsel of the U.S. Air Force, where he worked in government service until rejoining the firm in 1999. Matt was responsible for the department’s alternative dispute resolution program and for overseeing major litigation concerning national security information and the military and state secrets privilege, tort claims, environmental claims, bid protests, contract claims, and base closures, as well as for a wide range of non-litigation matters. He was awarded the Air Force Decoration for Exceptional Civilian Service. In 2021, he became Senior Counsel.

Distinctions

Auteurs associés

Cleary Gottlieb Steen & Hamilton (Cologne)
Cleary Gottlieb Steen & Hamilton (London)
Cleary Gottlieb Steen & Hamilton (Hong Kong)
Cleary Gottlieb Steen & Hamilton (Brussels)
Cleary Gottlieb Steen & Hamilton (Washington)

Articles

487 Bulletin

Jonathan I. Blackman, Boaz S. Morag, Carmine D. Boccuzzi Jr., Rathna Ramamurthi, Sarah Gutman, Matthew D. Slater The US Court of Appeals for the Second Circuit dismisses antitrust claims against two Chinese pharmaceutical companies for reasons of international comity (Animal Science Products / Hebei Welcome Pharmaceutical)

232

The U.S. Court of Appeals for the Second Circuit recently issued a 2-1 decision in In re Vitamin C Antitrust Litig., dismissing antitrust claims against two Chinese pharmaceutical companies for reasons of international comity in a case that has lasted over 15 years. On August 10, 2021, the (...)

Alexis Collins, Elizabeth Vicens, Matthew D. Slater, Nowell D. Bamberger The US Supreme Court issues a decision limiting the circumstances under which a federal agency may be compelled to disclose the confidential information received by the agency, from a private party (Food Marketing Institute / Argus Leader Media)

255

On June 24, 2019, the Supreme Court of the United States issued an important decision limiting the circumstances under which a federal agency may be compelled to disclose “confidential” information the agency received from a private party, and which the agency seeks to withhold under the Freedom (...)

Envoyer un message